4th of July Sale: Create a Free Seeking Alpha Account
Our 20% off sale is extended to 4th of July! Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings.

or
By creating an account using any of the options above, you agree to the Terms of Use & Privacy Policy

CARM Carisma Therapeutics, Inc.
Stock Price & Overview

$0.40-0.017 (-4.05%)1:00 PM 07/03/25
NASDAQ | $USD | Post-Market: $0.42 +0.01 (+3.08%) 4:59 PM

CARM Stock Price

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Latest Headlines

Ratings Summary

People Also Follow

Similar to CARM

ETFs Holding CARM

CARM Company Profile

Carisma Therapeutics, Inc. logo
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Employees
46
Founded
2016
Address
  • 3675 Market Street
  • Suite 401
  • Philadelphia, PA, 19104
  • United States
Phone Number
267 491 6422

CARM Revenue

CARM Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

Dividends

CARM does not currently pay a dividend.

CARM Ownership

CARM Peers

Risk

Technicals

CARM Transcripts

Investor Presentations

CARM SEC Filings

CARM Income Statement

CARM Balance Sheet

CARM Cash Flow Statement

CARM Long Term Solvency

Carisma Therapeutics, Inc. (CARM) Frequently Asked Questions